Cancer diagnosis may be linked with improved smoking cessation
the ONA take:
Research evidence indicates that a cancer diagnosis can stimulate smoking cessation. Little previous study research exists correlating smoking cessation with a diagnosis of cancer, though the event certainly provides the opportunity for a teachable moments in which an oncology may attempt to motivate a smoker to quit the habit.
Study author J. Lee Westmaas, PhD, and associates, based at the Behavioral Research Center, American Cancer Society, sought to determine if a link exists.
Participant data from the Cancer Prevention Study-II Nutrition Cohort was reviewed and a comparison made between the quit rates of smokers diagnosed with cancer at 2- and 4-year intervals and smokers not diagnosed with cancer. Individuals with cancers that could influence smoking (saucy as cancer of the lung or esophagus) were excluded from the review.
Both the 2-year and 4-year quit rate was found to be higher for smokers diagnosed with cancer. Even when the cancer diagnosis had a good prognosis or could not be directly linked to the smoking habit, the quit rate was found to be higher.
The investigation results suggest that a cancer diagnosis may indeed provide a teachable moment opportunity for oncology professionals.
Research evidence indicates that a cancer diagnosis can stimulate smoking cessation.
- Sexual Dysfunction in Women With Cancer: A Review of Available Interventions
- Osteoporosis Medication Improves Bone Health in ADT-Treated Prostate Cancer
- Inotuzumab Ozogamicin Granted FDA Approval for Acute Lymphoblastic Leukemia
- Cabazitaxel in Prostate Cancer: Reduced Dose Noninferior to Standard Dose
- Risk of Some Cancers Higher in Women With a History of Periodontal Disease
- To Better Serve Patients With Cancer, Navigators Need Better Systems
- Physical Activity Improves Cognitive Function for Breast Cancer Survivors
- Risk of Lung Cancer Increases With Diets Higher in Saturated Fats
- Mechanisms Identified for Curcumin Resensitization of Cancer Cells
- Value of Type and Crossmatch Prior to Daratumumab Administration
- Worse Survival Seen for Alternative Versus Usual Cancer Therapy
- Anorexia-Cachexia in Non-Small Cell Lung Cancer Improved With Anamorelin
- Early Recognition of Checkpoint Inhibitor-Related Pneumonitis Improves Outcomes
- Lenalidomide After ASCT Prolongs Time to Progression in Multiple Myeloma
- Arthritis Medication Shows Potential in the Treatment of Polycythemia Vera
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|